Are non-pharmacological local therapies still relevant?

While systemic drugs are gaining ground, local non-surgical interventions are carving out a significant niche. Technologies like cryoablation (freezing the tumor) and High-Intensity Focused Ultrasound (HIFU) provide a middle ground for patients with localized but symptomatic tumors that are not suitable for surgery.

How is the Desmoid Tumor Cryoablation Market growing in 2024?

The Desmoid Tumor Cryoablation Market is seeing increased uptake in 2024 as interventional radiologists refine their techniques. For medical device procurement, this represents a shift toward specialized probes and real-time intraoperative imaging. This modality is particularly attractive for pediatric patients where long-term systemic therapy might impact growth and development.

What are the competitive dynamics for 2025?

By 2025, the competition will not be between "drug vs. device," but rather about "sequencing." Strategic market leaders will promote integrated protocols where cryoablation is used to debulk a symptomatic tumor, followed by systemic therapy to prevent recurrence, creating a collaborative environment for both device and drug manufacturers.

• Minimally invasive approach with shorter recovery times.
• Repeatable procedures for recurrent nodules.
• Lower long-term systemic toxicity compared to drugs.

2025 Outlook for Local Therapies

In 2025, we expect more robust comparative effectiveness data between cryoablation and systemic agents. This will lead to clearer clinical guidelines, likely positioning local ablation for extra-abdominal tumors and systemic therapy for more complex, multi-focal, or mesenteric cases.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | [email protected]